6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 12 Nov 2025
- Reporting date
- 12 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
GSK plc reports
- Company location
- London
GSK plc has filed 6,806 SEC EDGAR filings since 12 Jan 2001
SEC filing history
Showing 251-275 of 1,000 matching filings.
Per page
25
Current page
11
6-K
File 001-15170
GSK PUBLISHES PROVISIONAL DIVIDEND DATES
- Filing date
- 10 Nov 2025
- Reporting date
- 10 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 10 Nov 2025
- Reporting date
- 10 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 07 Nov 2025
- Reporting date
- 07 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 06 Nov 2025
- Reporting date
- 06 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 05 Nov 2025
- Reporting date
- 05 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 04 Nov 2025
- Reporting date
- 04 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TOTAL VOTING RIGHTS
- Filing date
- 03 Nov 2025
- Reporting date
- 03 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 03 Nov 2025
- Reporting date
- 03 Nov 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 31 Oct 2025
- Reporting date
- 31 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
DIRECTOR/PDMR SHAREHOLDING
- Filing date
- 30 Oct 2025
- Reporting date
- 30 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 30 Oct 2025
- Reporting date
- 30 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 29 Oct 2025
- Reporting date
- 29 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
3RD QUARTER RESULTS
- Filing date
- 29 Oct 2025
- Reporting date
- 29 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 28 Oct 2025
- Reporting date
- 28 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
GSK ADC GETS ORPHAN DRUG DESIGNATION IN THE EU
- Filing date
- 28 Oct 2025
- Reporting date
- 28 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 27 Oct 2025
- Reporting date
- 27 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
BLENREP APPROVED BY US FDA IN MULTIPLE MYELOMA
- Filing date
- 24 Oct 2025
- Reporting date
- 24 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 24 Oct 2025
- Reporting date
- 24 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 23 Oct 2025
- Reporting date
- 23 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
POSITIVE DATA FOR LOW CARBON VERSION VENTOLIN MDI
- Filing date
- 22 Oct 2025
- Reporting date
- 22 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 22 Oct 2025
- Reporting date
- 22 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
LATOZINEMAB DATA READ OUT
- Filing date
- 22 Oct 2025
- Reporting date
- 22 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
POSITIVE CHMP OPINION FOR GSK ON SHINGRIX PFS
- Filing date
- 21 Oct 2025
- Reporting date
- 21 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
6-K
File 001-15170
TRANSACTION IN OWN SHARES
- Filing date
- 21 Oct 2025
- Reporting date
- 21 Oct 2025
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing